Evidence map›Paper›PMID 40523798›Full record

ArticleLife science alliance2025

hnRNP A1 induces aberrant

Christelle Beaumont, Cristiana Stuani, Ming-Yuan Chou, Huma Shakoor, Maria Zlobina, Veronica Palaggi, Emanuele Buratti, Peter Josef Lukavsky

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life science alliance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christelle BeaumontCEITEC- Central European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID 0000-0002-6010-3015
Cristiana StuaniInternational Centre for Genetic Engineering and Biotechnology, Trieste, Italy.ORCID 0009-0007-3579-0670
Ming-Yuan ChouCEITEC- Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
Huma ShakoorCEITEC- Central European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID 0009-0009-6398-3837
Maria ZlobinaCEITEC- Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
Veronica PalaggiCEITEC- Central European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID 0009-0009-5963-7878
Emanuele BurattiInternational Centre for Genetic Engineering and Biotechnology, Trieste, Italy.ORCID 0000-0002-1356-9074
Peter Josef LukavskyCEITEC- Central European Institute of Technology, Masaryk University, Brno, Czech Republic peter.lukavsky@ceitec.muni.cz.ORCID 0000-0003-2935-1579

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA-protein interactions play a key role in the aberrant splicing of

Indexed as

Cystic Fibrosis Transmembrane Conductance RegulatorHeterogeneous Nuclear Ribonucleoprotein A1RNA SplicingAlternative SplicingBinding SitesCystic FibrosisExonsHumansProtein BindingRNA PrecursorsRNA Splice SitesCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorHeterogeneous Nuclear Ribonucleoprotein A1hnRNPA1 protein, humanRNA PrecursorsRNA Splice Sites

Identifiers

PMID40523798
PMCPMC12171016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.